Imidazolium salts as small-molecule urinary bladder exfoliants in a murine model

Keyphrases

• Murine Model 100%
• Bladder 100%
• Small Molecules 100%
• Urinary Bladder 100%
• Imidazolium Salts 100%
• Exfoliants 100%
• Bladder Urothelium 66%
• Protamine Sulfate 66%
• Antimicrobial 33%
• Escherichia Coli 33%
• Immunofluorescence 33%
• Physiologically Relevant 33%
• Immunoblotting 33%
• Tissue Injury 33%
• Therapeutic Potential 33%
• Bladder Pain Syndrome 33%
• Conjugation 33%
• Bladder Cancer 33%
• Systemic Side Effects 33%
• Microscopy 33%
• Novel Family 33%
• Urologic 33%
• Cystitis 33%
• Cancer Pain 33%
• Urologic Diseases 33%
• Uroepithelium 33%
• Exfoliating 33%
• Epithelial Exfoliation 33%
• Normal Appearance 33%
• Chemical Scaffolds 33%
• Translational Potential 33%
• Intravesical 33%
• No Toxicity 33%
• Lyophilization 33%
• Uropathogens 33%
• Uroepithelial Cells 33%
• Intravesical Administration 33%
• Imidazolium 33%
• Exfoliating Agent 33%
• Contact Time 33%
• Cationic Peptides 33%
• Uroplakin 33%
• Compound Family 33%

Medicine and Dentistry

• Bladder 100%
• Protamine Sulfate 50%
• Intravesical Drug Administration 50%
• Bladder Epithelium 50%
• Adverse Event 25%
• Immunoblotting 25%
• Cystalgia 25%
• Bladder Cancer 25%
• Urothelium 25%
• Cystitis 25%
• Tissue Injury 25%
• Copurification 25%
• Escherichia coli 25%
• Immunofluorescence Microscopy 25%
• Bladder Tissue 25%
• Uroplakin 25%
• Chemotherapy 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Protamine Sulfate 100%
• Adverse Event 50%
• Western Blot 50%
• Escherichia coli 50%
• Tissue Injury 50%
• Preclinical Study 50%
• Cystitis 50%
• Bladder Cancer 50%
• Cystalgia 50%
• Uroplakin 50%